Applied BioCode Corporation (TPE:6598)
23.35
-0.20 (-0.85%)
At close: Mar 27, 2026
Applied BioCode Market Cap
Applied BioCode has a market cap or net worth of 2.4 billion as of March 27, 2026. Its market cap has decreased by -0.83% in one year.
Market Cap
2.40B
Enterprise Value
1.89B
Revenue
475.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.35
Market Cap Chart
Since February 9, 2017, Applied BioCode's market cap has decreased from 3.23B to 2.40B, a decrease of -25.58%. That is a compound annual growth rate of -3.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 2.40B | 6.14% |
| Dec 31, 2025 | 2.26B | 9.21% |
| Dec 31, 2024 | 2.07B | 0.12% |
| Dec 29, 2023 | 2.07B | -18.38% |
| Dec 30, 2022 | 2.53B | -27.88% |
| Dec 30, 2021 | 3.51B | -26.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonraybio | 4.12B |
| WeLeader Biomedical | 3.11B |
| Medimaging Integrated Solution | 2.87B |
| A Plus Biotechnology | 2.71B |
| Dynamic Medical Technologies | 2.44B |
| Wellell | 2.25B |
| Taiwan Biomaterial | 1.89B |
| OK Biotech | 1.88B |